EKF Diagnostics said this week that it will launch its PointMan DNA enrichment kits at the American Society for Clinical Oncology meeting later this month in Chicago.

The company is commercializing three kits to enrich mutations in BRAF, KRAS, and EGFR T790M genes associated with melanoma, colorectal, and lung cancers. According to the company, PointMan kits offer highly specific and ultra-sensitive enrichment of mutant genes in a background of wild-type genes that is "unmatched" by existing technologies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.